
Symposiums
Here at the Chi-li Pao Foundation USA, we are dedicated to educating medical professionals and university faculty on important health topics through our medical symposiums. Our goal is to share knowledge and help everyone access the latest medical advancements, treatments, and practices to improve their health outcomes. We believe that to better someone’s health, education and awareness is key and that’s what we provide.

Stanford Medicine Symposium 2023: Novel Strategies for the Treatment of Neurologic Disorder
Distinguished faculty and experts from Stanford University School of Medicine and the Greater China discussed:
• Treatment of brain tumors using Cyberknife, Car-T cells, and immunotherapy
• Advances in complex intracranial aneurysms interventions
• Developments in pediatric neurosurgery
• Brain-computer interface to restore brain function
• Multidisciplinary spine care
• Robotic spine surgery using artificial intelligence
The meeting will provide the opportunity to exchange information and ideas to explore collaboration for both clinical work and basic science research.

Stanford Medicine Symposium 2019: Lung Cancer
In this multidisciplinary symposium, physicians explored:
-
The unique challenges and opportunities to improve lung cancer care and reduce lung cancer mortality
-
Similarities and differences in multidisciplinary cancer care in China and the United States
-
Ways to foster collaborations between China and the United States for both lung cancer clinical work and research

Annual Virtual International Medical Student Research Symposium
The Stanford Annual Virtual International Medical Student Research Symposium is a dynamic platform that brings together aspiring medical students from around the globe to present and discuss their innovative research endeavors. This symposium serves as a forum for showcasing diverse medical research projects, fostering collaboration, and encouraging scholarly exchange among students passionate about advancing healthcare. Through virtual presentations, poster sessions, and interactive discussions, participants share their findings across various medical disciplines, gaining valuable insights, mentorship, and networking opportunities. The symposium aims to inspire the next generation of healthcare leaders, promoting excellence in medical research and encouraging cross-cultural engagement in the pursuit of medical knowledge.
​
This Symposium is less structured and formal than other research conferences in order to encourage medical students to communicate the research part of their educational program that is often not shared with their peers.
​
Research can be in progress or finished; must have a Stanford faculty advisor; and may be a part of an outside fellowship (e.g. Howard Hughes, Sarnoff, etc), internal fellowship (Medical Scholars), research assistantship, MD/PhD program, or Directed Research.

Stanford Medicine Symposium 2018: Cardiovascular Medicine
The CVI leadership event included presentations from leaders of major pharmaceutical companies, federal and foundation policy makers, and scientists making groundbreaking advances in the drug discovery space. Highlights include: the presentation of a Lifetime Achievement Award to Dr. Roy Vagelos (former CEO of Merck and current Chair of Regeneron); a Keynote Address from Dr. Brian Kobilka (Nobel Prize in Chemistry, 2012); a Fireside Chat with Stanford University President Marc Tessier-Lavigne, PhD, and Stanford School of Medicine Dean Lloyd Minor, MD; a panel discussion with editors representing the New England Journal of Medicine, JAMA, Science, and Nature Reviews Drug Discovery; and View from the Top presentations by biotechnology industry leaders Ken Frazier (CEO of Merck), Bob Bradway (CEO of Amgen) Joe Jimenez (Former CEO of Novartis), Jeff Leiden (CEO of Vertex), Patrick Soon-Shiong (CEO of Nantworks), and George Scangos (CEO of Vir).
In addition, researchers engaged in clinical and translational stage projects will have the opportunity to present their ideas in an interactive shark-tank style competition judged by a panel of CEOs